CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing elderly population
4.1.2. Increasing prevalence of cardio vascular diseases
4.1.3. Technological advancements in vascular imaging devices
4.1.4. The rise in demand for minimally invasive diagnosis and treatment
4.2. Market Restraints & Challenges
4.2.1. Lack of medical physicists
4.2.2. The high cost of vascular imaging instruments
4.2.3. Availability of conventional treatments
4.3. Market Opportunities
4.3.1. Increase in the number of diagnostic imaging centres
4.3.2. Emerging economies
CHAPTER 5 GLOBAL VASCULAR IMAGING MARKET – BY PROCEDURE
5.1. Coronary Angiography
5.2. Peripheral Angiography
5.3. Neurovascular Angiography
5.4. Vascular Ultrasound Procedures
5.5. Micro angiography
5.6. Others
CHAPTER 6 GLOBAL VASCULAR IMAGING MARKET – BY TECHNIQUE
6.1. Magnetic Resonance Imaging
6.2. Ultrasound
6.3. Computed Tomography
6.4. Nuclear Imaging
6.5. X-Ray
CHAPTER 7 GLOBAL VASCULAR IMAGING MARKET – BY APPLICATION
7.1. Diagnostic Applications
7.2. Therapeutic Applications
CHAPTER 8 GLOBAL VASCULAR IMAGING MARKET – BY END USER
8.1. Hospitals
8.2. Diagnostic Imaging Centers
8.3. Other End User
CHAPTER 9 GLOBAL VASCULAR IMAGING MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL VASCULAR IMAGING MARKET - COMPANY PROFILES
10.1. Toshiba Corporation
10.2. Siemens AG
10.3. GE Healthcare
10.4. Hitachi Medical Corporation
10.5. Koninklijke Philips N.V.
10.6. Shimadzu Medical Systems
10.7. Samsung Medison
10.8. Abbott Laboratories
10.9. Hologic Inc.
10.10. Fujifilm Corporation
10.11. Esaote SPA
10.12. Terumo Corporation
10.13. Care stream Health Inc.
10.14. Alpinion Medical Systems Co. Ltd
10.15. Omega Medical Imaging, LLC.
CHAPTER 11 GLOBAL VASCULAR IMAGING MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
